Protein kinase C delta and prokineticin-2 signaling in experimental models of neuroinflammation and Parkinson's disease

@inproceedings{Gordon2011ProteinKC,
  title={Protein kinase C delta and prokineticin-2 signaling in experimental models of neuroinflammation and Parkinson's disease},
  author={R. Gordon},
  year={2011}
}
iv CHAPTER I. GENERAL INTRODUCTION Dissertation Organization 0 
View via Publisher
lib.dr.iastate.edu

Figures and Tables from this paper

References

SHOWING 1-10 OF 306 REFERENCES
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
  • 102
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases
  • 42
MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease
  • 258
  • Highly Influential
Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET
  • A. Bartels, K. Leenders
  • Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2007
  • 115
Cannabinoids in Microglia: A New Trick for Immune Surveillance and Neuroprotection
  • 24
The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
  • 181
TNF-R1 Signaling: A Beautiful Pathway
  • 1,674
  • PDF
Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta.
  • 56
  • PDF
Genetic Inactivation of Prokineticin Receptor-1 Leads to Heart and Kidney Disorders
  • 21
  • PDF
Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis.
  • 123
  • Highly Influential
...
1
2
3
4
5
...